ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients

Detalles Bibliográficos
Autores principales: Daoud, Ahmed, Ali, Hatem, Rao, Vinaya, Rohan, Vinayak, Soliman, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555537/
https://www.ncbi.nlm.nih.gov/pubmed/34704916
http://dx.doi.org/10.1080/0886022X.2021.1994419
_version_ 1784591997545218048
author Daoud, Ahmed
Ali, Hatem
Rao, Vinaya
Rohan, Vinayak
Soliman, Karim
author_facet Daoud, Ahmed
Ali, Hatem
Rao, Vinaya
Rohan, Vinayak
Soliman, Karim
author_sort Daoud, Ahmed
collection PubMed
description
format Online
Article
Text
id pubmed-8555537
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-85555372021-10-30 ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients Daoud, Ahmed Ali, Hatem Rao, Vinaya Rohan, Vinayak Soliman, Karim Ren Fail Letter to the Editor Taylor & Francis 2021-10-27 /pmc/articles/PMC8555537/ /pubmed/34704916 http://dx.doi.org/10.1080/0886022X.2021.1994419 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Daoud, Ahmed
Ali, Hatem
Rao, Vinaya
Rohan, Vinayak
Soliman, Karim
ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
title ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
title_full ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
title_fullStr ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
title_full_unstemmed ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
title_short ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
title_sort ace-inhibitor/angiotensin receptor blockers (ace-i/arbs) therapy in covid-19 infected dialysis patients
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555537/
https://www.ncbi.nlm.nih.gov/pubmed/34704916
http://dx.doi.org/10.1080/0886022X.2021.1994419
work_keys_str_mv AT daoudahmed aceinhibitorangiotensinreceptorblockersaceiarbstherapyincovid19infecteddialysispatients
AT alihatem aceinhibitorangiotensinreceptorblockersaceiarbstherapyincovid19infecteddialysispatients
AT raovinaya aceinhibitorangiotensinreceptorblockersaceiarbstherapyincovid19infecteddialysispatients
AT rohanvinayak aceinhibitorangiotensinreceptorblockersaceiarbstherapyincovid19infecteddialysispatients
AT solimankarim aceinhibitorangiotensinreceptorblockersaceiarbstherapyincovid19infecteddialysispatients

Ejemplares similares